Literature DB >> 21427239

Contact by melanoma cells causes malignant transformation of human epithelial-like stem cells via alpha V integrin activation of transforming growth factor β1 signaling.

Hongyu Sun1, Kaimeng Hu, Minjuan Wu, Jun Xiong, Li Yuan, Ying Tang, Yongji Yang, Houqi Liu.   

Abstract

The embryonic microenvironment is known to suppress the tumorigenic phenotype of aggressive cancer cells; however, the effects of tumorigenic microenvironments on stem cells have not been sufficiently explored due to the lack of suitable model systems. In order to study the tumorigenic microenviornment, we developed a novel in vitro model system for induction of malignant transformation of human epithelial-like stem cells (hEpSCs), involving co-cultivation and close contact of hEpSCs with the A375 melanoma cell line, together with mutagen treatment of hEpSCs with dimethylbenzanthracene (DMBA). Both factors (close contact and mutagen treatment) were required to transform hEpSCs in vitro and cause phenotypic changes characteristic of epithelial to mesenchymal transition (EMT), including colony formation, decreased E-cadherin and increased N-cadherin and vimentin expression. Direct contact between tumor cells and hEpSCs treated with DMBA increased integrin alpha V (ITGAV gene) expression and caused local activation of the transforming growth factor (TGF)-β1/Smad signaling pathways in hEpSCs. The novel model system described here is being used to elucidate the microenvironmental factors and biological mechanisms involved in the induction of neoplastic progression in hEpSCs in vitro by A375 melanoma cells. A better understanding of the molecular mechanisms by which melanoma cells exert these effects on hEpSCs may open up new avenues for therapeutic and preventive cancer interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21427239     DOI: 10.1258/ebm.2010.010106

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  5 in total

1.  Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition.

Authors:  Jun-Shan Ruan; Yu-Ping Liu; Lei Zhang; Ling-Geng Yan; Fang-Tian Fan; Cun-Si Shen; Ai-Yun Wang; Shi-Zhong Zheng; Shao-Ming Wang; Yin Lu
Journal:  Acta Pharmacol Sin       Date:  2012-09-17       Impact factor: 6.150

2.  Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recovery.

Authors:  Tove Lekva; Jens Petter Berg; Ansgar Heck; Stine Lyngvi Fougner; Ole Kristoffer Olstad; Geir Ringstad; Jens Bollerslev; Thor Ueland
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

3.  αV integrin induces multicellular radioresistance in human nasopharyngeal carcinoma via activating SAPK/JNK pathway.

Authors:  Juanjuan Ou; Wei Luan; Jia Deng; Rina Sa; Houjie Liang
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

4.  The Response of microRNAs to Solar UVR in Skin-Resident Melanocytes Differs between Melanoma Patients and Healthy Persons.

Authors:  Jingfeng Sha; Brian R Gastman; Nathan Morris; Natasha A Mesinkovska; Elma D Baron; Kevin D Cooper; Thomas McCormick; Joshua Arbesman; Marian L Harter
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

5.  A Penicillin Derivative Exerts an Anti-Metastatic Activity in Melanoma Cells Through the Downregulation of Integrin αvβ3 and Wnt/β-Catenin Pathway.

Authors:  Elizabeth Barrionuevo; Florencia Cayrol; Graciela A Cremaschi; Patricia G Cornier; Dora B Boggián; Carina M L Delpiccolo; Ernesto G Mata; Leonor P Roguin; Viviana C Blank
Journal:  Front Pharmacol       Date:  2020-02-25       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.